EU medtech industry keeps eye on Portuguese treaty moves:
This article was originally published in Clinica
Executive Summary
The Portuguese presidency of the EU Council is hoping to secure a political agreement on the European Union treaty by mid-October, and is targeting text sign-off by the end of the year. National leaders were due to meet on September 7 with the aim of strengthening the functioning and management of the 27-member EU. This should enable it to become more influential on a global level, politically and economically, and on an industrial level - with obvious repercussions for the medtech industry, among others. The new treaty, as currently proposed, would provide for a permanent president, and, from 2014, would give national parliaments a greater role. The issue remains highly political, and the text has many opponents.
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.